Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Roivant Sciences Ltd.(ROIV US)

$39.53-0.461.15%Ext:$41.17+1.644.15%(After Hours · 23:02:54 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Roivant Sciences Ltd.(ROIV US)

$39.53-0.461.15%Ext:$41.17+1.644.15%(After Hours · 23:02:54 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

ROIV US

ROIV US

SEC Filings

SEC Filings

Financials(22)

10-QQ2ended 30 Sept 20269 Nov
10-QQ1ended 30 Jun 20266 Aug
10-KFY 2026ended 31 Mar 202620 May
10-QQ3ended 31 Dec 20256 Feb
10-QQ2ended 30 Sept 202510 Nov 2025
10-QQ1ended 30 Jun 202511 Aug 2025
10-KFY 2025ended 31 Mar 202529 May 2025
10-QQ3ended 31 Dec 202410 Feb 2025
10-QQ2ended 30 Sept 202412 Nov 2024
10-QQ1ended 30 Jun 20249 Aug 2024
10-KFY 2024ended 31 Mar 202430 May 2024
10-QQ3ended 31 Dec 202313 Feb 2024
10-QQ2ended 30 Sept 202313 Nov 2023
10-QQ1ended 30 Jun 202314 Aug 2023
10-KFY 2023ended 31 Mar 202328 Jun 2023

Events(83)

8-KResults of Operations and Financial Condition9 Nov
8-KRegulation FD Disclosure21 Oct
8-KSubmission of Matters to a Vote of Security Holders18 Sep
8-KRegulation FD Disclosure8 Sep
8-KOther Events28 Aug
8-KRegulation FD Disclosure27 Aug
8-KResults of Operations and Financial Condition6 Aug
8-KResults of Operations and Financial Condition20 May
8-KResults of Operations and Financial Condition2 Apr
8-K/AEntry into a Material Definitive Agreement23 Mar
8-KEntry into a Material Definitive Agreement3 Mar
8-KRegulation FD Disclosure3 Mar
8-KResults of Operations and Financial Condition6 Feb
8-KRegulation FD Disclosure11 Dec 2025
8-KResults of Operations and Financial Condition10 Nov 2025

Insider Ownership(511)

Form 4Torti Frank12 Nov
Form 4Gline Matthew12 Nov
Form 4Sukhatme Mayukh12 Nov
Form 4Pulik Richard12 Nov
Form 4Venker Eric12 Nov
Form 4Venker Eric5 Nov
Form 4Venker Eric30 Oct
Form 4Oren Ilan27 Oct
Form 4Epperly Melissa B,27 Oct
Form 4MOMTAZEE JAMES C27 Oct
Form 4Venker Eric22 Oct
Form 4Sukhatme Mayukh20 Oct
Form 4Gline Matthew20 Oct
Form 4Roivant Sciences Ltd.5 Oct
Form 4Epperly Melissa B,5 Oct

Beneficial Ownership(96)

SC 13G/ARoivant Sciences Ltd.5 Nov
SC 13G/ARoivant Sciences Ltd.27 Oct
SC 13D/AArbutus Biopharma Corp5 Oct
SC 13G/ARoivant Sciences Ltd.13 Aug
SC 13G/ARoivant Sciences Ltd.12 May
SC 13G/ARoivant Sciences Ltd.6 May
SC 13G/ARoivant Sciences Ltd.27 Mar
SC 13G/ARoivant Sciences Ltd.6 Mar
SC 13G/ARoivant Sciences Ltd.17 Feb
SC 13G/ARoivant Sciences Ltd.13 Feb
SC 13G/ARoivant Sciences Ltd.11 Feb
SC 13G/ARoivant Sciences Ltd.5 Feb
SC 13D/AImmunovant, Inc.12 Dec 2025
SC 13G/ARoivant Sciences Ltd.14 Nov 2025
SC 13G/ARoivant Sciences Ltd.14 Nov 2025

Other Ownership(196)

Form 144/APulik Richard05:46PM
Form 144/APulik Richard05:45PM
Form 144Pulik Richard12 Nov
Form 144/ATorti Frank10 Nov
Form 144/AGline Matthew10 Nov
Form 144/ASukhatme Mayukh10 Nov
Form 144Venker Eric10 Nov
Form 144Sukhatme Mayukh10 Nov
Form 144Gline Matthew10 Nov
Form 144Torti Frank10 Nov
Form 144Pulik Richard10 Nov
Form 144Venker Eric3 Nov
Form 144Venker Eric28 Oct
Form 144Venker Eric20 Oct
Form 144Venker Eric30 Sep

Proxies(14)

ARSAnnual report to security holders29 Jul
DEFA14ADefinitive additional materials29 Jul
DEF 14ADefinitive proxy statement29 Jul
DEF 14ADefinitive proxy statement29 Jul 2025
DEFA14ADefinitive additional materials29 Jul 2025
ARSAnnual report to security holders29 Jul 2025
ARSAnnual report to security holders26 Jul 2024
DEFA14ADefinitive additional materials26 Jul 2024
DEF 14ADefinitive proxy statement26 Jul 2024
ARSAnnual report to security holders7 Aug 2023
DEF 14ADefinitive proxy statement31 Jul 2023
DEFA14ADefinitive additional materials31 Jul 2023
DEFA14ADefinitive additional materials26 Jul 2022
DEF 14ADefinitive proxy statement26 Jul 2022

Registrations(62)

S-8Registration statement (employee benefit plan)20 May
S-3ASRAutomatic shelf registration statement (S-3)3 Oct 2025
S-8Registration statement (employee benefit plan)26 Jul 2024
424B5Prospectus filing (Rule 424(b)(5))6 Oct 2023
S-3Registration statement (primary offering)29 Sep 2023
424B5Prospectus filing (Rule 424(b)(5))26 Sep 2023
25-NSENotification of removal from listing1 Sep 2023
S-8Registration statement (employee benefit plan)29 Jun 2023
424B5Prospectus filing (Rule 424(b)(5))6 Feb 2023
424B5Prospectus filing (Rule 424(b)(5))1 Feb 2023
424B5Prospectus filing (Rule 424(b)(5))9 Nov 2022
424B5Prospectus filing (Rule 424(b)(5))8 Nov 2022
424B7Prospectus filing (Rule 424(b)(7))3 Oct 2022
424B5Prospectus filing (Rule 424(b)(5))3 Oct 2022
424B5Prospectus filing (Rule 424(b)(5))3 Oct 2022

Filing Review Correspondence(10)

CORRESPFiling review correspondence4 Oct 2023
CORRESPFiling review correspondence28 Mar 2022
CORRESPFiling review correspondence28 Feb 2022
CORRESPFiling review correspondence24 Feb 2022
CORRESPFiling review correspondence30 Dec 2021
CORRESPFiling review correspondence5 Nov 2021
CORRESPFiling review correspondence6 Aug 2021
CORRESPFiling review correspondence3 Aug 2021
CORRESPFiling review correspondence22 Jul 2021
CORRESPFiling review correspondence30 Jun 2021

SEC Orders And Notices(10)

EFFECTNotice of effectiveness6 Oct 2023
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness2 Aug 2022
EFFECTNotice of effectiveness31 Mar 2022
EFFECTNotice of effectiveness4 Jan 2022
EFFECTNotice of effectiveness9 Nov 2021
EFFECTNotice of effectiveness10 Aug 2021

Other(3)

CERTCERT1 Oct 2021
SEC STAFF LETTERSEC STAFF LETTER10 Aug 2021
SEC STAFF LETTERSEC STAFF LETTER17 Jun 2021

Financials(22)

10-QQ2ended 30 Sept 20269 Nov
10-QQ1ended 30 Jun 20266 Aug
10-KFY 2026ended 31 Mar 202620 May
10-QQ3ended 31 Dec 20256 Feb
10-QQ2ended 30 Sept 202510 Nov 2025
10-QQ1ended 30 Jun 202511 Aug 2025
10-KFY 2025ended 31 Mar 202529 May 2025
10-QQ3ended 31 Dec 202410 Feb 2025
10-QQ2ended 30 Sept 202412 Nov 2024
10-QQ1ended 30 Jun 20249 Aug 2024
10-KFY 2024ended 31 Mar 202430 May 2024
10-QQ3ended 31 Dec 202313 Feb 2024
10-QQ2ended 30 Sept 202313 Nov 2023
10-QQ1ended 30 Jun 202314 Aug 2023
10-KFY 2023ended 31 Mar 202328 Jun 2023

Events(83)

8-KResults of Operations and Financial Condition9 Nov
8-KRegulation FD Disclosure21 Oct
8-KSubmission of Matters to a Vote of Security Holders18 Sep
8-KRegulation FD Disclosure8 Sep
8-KOther Events28 Aug
8-KRegulation FD Disclosure27 Aug
8-KResults of Operations and Financial Condition6 Aug
8-KResults of Operations and Financial Condition20 May
8-KResults of Operations and Financial Condition2 Apr
8-K/AEntry into a Material Definitive Agreement23 Mar
8-KEntry into a Material Definitive Agreement3 Mar
8-KRegulation FD Disclosure3 Mar
8-KResults of Operations and Financial Condition6 Feb
8-KRegulation FD Disclosure11 Dec 2025
8-KResults of Operations and Financial Condition10 Nov 2025

Insider Ownership(511)

Form 4Torti Frank12 Nov
Form 4Gline Matthew12 Nov
Form 4Sukhatme Mayukh12 Nov
Form 4Pulik Richard12 Nov
Form 4Venker Eric12 Nov
Form 4Venker Eric5 Nov
Form 4Venker Eric30 Oct
Form 4Oren Ilan27 Oct
Form 4Epperly Melissa B,27 Oct
Form 4MOMTAZEE JAMES C27 Oct
Form 4Venker Eric22 Oct
Form 4Sukhatme Mayukh20 Oct
Form 4Gline Matthew20 Oct
Form 4Roivant Sciences Ltd.5 Oct
Form 4Epperly Melissa B,5 Oct

Beneficial Ownership(96)

SC 13G/ARoivant Sciences Ltd.5 Nov
SC 13G/ARoivant Sciences Ltd.27 Oct
SC 13D/AArbutus Biopharma Corp5 Oct
SC 13G/ARoivant Sciences Ltd.13 Aug
SC 13G/ARoivant Sciences Ltd.12 May
SC 13G/ARoivant Sciences Ltd.6 May
SC 13G/ARoivant Sciences Ltd.27 Mar
SC 13G/ARoivant Sciences Ltd.6 Mar
SC 13G/ARoivant Sciences Ltd.17 Feb
SC 13G/ARoivant Sciences Ltd.13 Feb
SC 13G/ARoivant Sciences Ltd.11 Feb
SC 13G/ARoivant Sciences Ltd.5 Feb
SC 13D/AImmunovant, Inc.12 Dec 2025
SC 13G/ARoivant Sciences Ltd.14 Nov 2025
SC 13G/ARoivant Sciences Ltd.14 Nov 2025

Other Ownership(196)

Form 144/APulik Richard05:46PM
Form 144/APulik Richard05:45PM
Form 144Pulik Richard12 Nov
Form 144/ATorti Frank10 Nov
Form 144/AGline Matthew10 Nov
Form 144/ASukhatme Mayukh10 Nov
Form 144Venker Eric10 Nov
Form 144Sukhatme Mayukh10 Nov
Form 144Gline Matthew10 Nov
Form 144Torti Frank10 Nov
Form 144Pulik Richard10 Nov
Form 144Venker Eric3 Nov
Form 144Venker Eric28 Oct
Form 144Venker Eric20 Oct
Form 144Venker Eric30 Sep

Proxies(14)

ARSAnnual report to security holders29 Jul
DEFA14ADefinitive additional materials29 Jul
DEF 14ADefinitive proxy statement29 Jul
DEF 14ADefinitive proxy statement29 Jul 2025
DEFA14ADefinitive additional materials29 Jul 2025
ARSAnnual report to security holders29 Jul 2025
ARSAnnual report to security holders26 Jul 2024
DEFA14ADefinitive additional materials26 Jul 2024
DEF 14ADefinitive proxy statement26 Jul 2024
ARSAnnual report to security holders7 Aug 2023
DEF 14ADefinitive proxy statement31 Jul 2023
DEFA14ADefinitive additional materials31 Jul 2023
DEFA14ADefinitive additional materials26 Jul 2022
DEF 14ADefinitive proxy statement26 Jul 2022

Registrations(62)

S-8Registration statement (employee benefit plan)20 May
S-3ASRAutomatic shelf registration statement (S-3)3 Oct 2025
S-8Registration statement (employee benefit plan)26 Jul 2024
424B5Prospectus filing (Rule 424(b)(5))6 Oct 2023
S-3Registration statement (primary offering)29 Sep 2023
424B5Prospectus filing (Rule 424(b)(5))26 Sep 2023
25-NSENotification of removal from listing1 Sep 2023
S-8Registration statement (employee benefit plan)29 Jun 2023
424B5Prospectus filing (Rule 424(b)(5))6 Feb 2023
424B5Prospectus filing (Rule 424(b)(5))1 Feb 2023
424B5Prospectus filing (Rule 424(b)(5))9 Nov 2022
424B5Prospectus filing (Rule 424(b)(5))8 Nov 2022
424B7Prospectus filing (Rule 424(b)(7))3 Oct 2022
424B5Prospectus filing (Rule 424(b)(5))3 Oct 2022
424B5Prospectus filing (Rule 424(b)(5))3 Oct 2022

Filing Review Correspondence(10)

CORRESPFiling review correspondence4 Oct 2023
CORRESPFiling review correspondence28 Mar 2022
CORRESPFiling review correspondence28 Feb 2022
CORRESPFiling review correspondence24 Feb 2022
CORRESPFiling review correspondence30 Dec 2021
CORRESPFiling review correspondence5 Nov 2021
CORRESPFiling review correspondence6 Aug 2021
CORRESPFiling review correspondence3 Aug 2021
CORRESPFiling review correspondence22 Jul 2021
CORRESPFiling review correspondence30 Jun 2021

SEC Orders And Notices(10)

EFFECTNotice of effectiveness6 Oct 2023
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness3 Oct 2022
EFFECTNotice of effectiveness2 Aug 2022
EFFECTNotice of effectiveness31 Mar 2022
EFFECTNotice of effectiveness4 Jan 2022
EFFECTNotice of effectiveness9 Nov 2021
EFFECTNotice of effectiveness10 Aug 2021

Other(3)

CERTCERT1 Oct 2021
SEC STAFF LETTERSEC STAFF LETTER10 Aug 2021
SEC STAFF LETTERSEC STAFF LETTER17 Jun 2021